Recombinant Human ITIH5 protein (Tagged)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human ITIH5 protein (Tagged) is a Human Fragment protein, in the 35 to 161 aa range, expressed in Escherichia coli, with >90%, suitable for SDS-PAGE.
View Alternative Names
KIAA1953, PP14776, UNQ311/PRO354, ITIH5, Inter-alpha-trypsin inhibitor heavy chain H5, ITI heavy chain H5, ITI-HC5, Inter-alpha-inhibitor heavy chain 5
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human ITIH5 protein (Tagged) (AB238235)
(Tris-Glycine gel) Discontinuous DSD-PAGE (reduced) with 5% enrichment gel and 15% separation gel analysis of ab238235.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ITIH5 plays a role in extracellular matrix stabilization and tissue homeostasis. This protein participates in forming a protein complex with other inter-alpha-trypsin inhibitors which contributes to its functional capacity. ITIH5 shows importance in processes like cellular senescence and maintaining tissue integrity making it a relevant target in the context of cellular and systemic homeostasis.
Pathways
Several biological processes incorporate ITIH5 particularly those related to matrix remodeling and inflammation. One significant pathway involves the hyaluronan biosynthesis where ITIH5 interacts with proteins like TSG-6 facilitating the matrix assembly and stability. Another relevant interaction includes its association with matrix metalloproteinases mediating tissue remodeling during wound healing and inflammatory responses.
Specifications
Form
Liquid
General info
Function
May act as a tumor suppressor.
Sequence similarities
Belongs to the ITIH family.
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com